Patrick M. Dolan

3.7k total citations · 2 hit papers
28 papers, 3.1k citations indexed

About

Patrick M. Dolan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Patrick M. Dolan has authored 28 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 9 papers in Genetics. Recurrent topics in Patrick M. Dolan's work include Vitamin D Research Studies (10 papers), Estrogen and related hormone effects (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Patrick M. Dolan is often cited by papers focused on Vitamin D Research Studies (10 papers), Estrogen and related hormone effects (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Patrick M. Dolan collaborates with scholars based in United States, Japan and Ireland. Patrick M. Dolan's co-authors include Thomas W. Kensler, Masayuki Yamamoto, Paul Talalay, Minerva Ramos‐Gómez, Mi-Kyoung Kwak, Ken Itoh, Alain Lozniewski, X. Haristoy, Jed W. Fahey and Katherine K. Stephenson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Journal of Medicinal Chemistry.

In The Last Decade

Patrick M. Dolan

27 papers receiving 3.0k citations

Hit Papers

Sensitivity to carcinogenesis is increased and chemoprote... 2001 2026 2009 2017 2001 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick M. Dolan United States 18 2.4k 486 408 236 235 28 3.1k
Guoxiang Shen United States 29 3.1k 1.3× 492 1.0× 438 1.1× 242 1.0× 358 1.5× 40 4.2k
Vidya Hebbar United States 23 2.0k 0.8× 402 0.8× 344 0.8× 172 0.7× 334 1.4× 24 2.7k
Rong Hu United States 25 2.2k 0.9× 346 0.7× 227 0.6× 157 0.7× 190 0.8× 44 2.9k
Yen‐Chou Chen Taiwan 32 2.0k 0.8× 322 0.7× 520 1.3× 150 0.6× 376 1.6× 83 3.6k
Eun‐Ryeong Hahm United States 35 1.8k 0.7× 288 0.6× 447 1.1× 171 0.7× 197 0.8× 84 3.2k
Sujit Nair India 25 1.7k 0.7× 277 0.6× 300 0.7× 211 0.9× 251 1.1× 65 2.7k
Wanda Baer‐Dubowska Poland 35 2.0k 0.8× 335 0.7× 279 0.7× 158 0.7× 268 1.1× 136 3.5k
Zheng‐Yuan Su United States 29 2.0k 0.8× 235 0.5× 308 0.8× 128 0.5× 209 0.9× 54 2.9k
Philip J. Sherratt United Kingdom 14 2.1k 0.9× 190 0.4× 255 0.6× 201 0.9× 124 0.5× 16 2.6k
Mark A. Morse United States 28 2.0k 0.8× 466 1.0× 531 1.3× 206 0.9× 264 1.1× 74 2.9k

Countries citing papers authored by Patrick M. Dolan

Since Specialization
Citations

This map shows the geographic impact of Patrick M. Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Dolan more than expected).

Fields of papers citing papers by Patrick M. Dolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Dolan. The network helps show where Patrick M. Dolan may publish in the future.

Co-authorship network of co-authors of Patrick M. Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. Dolan. A scholar is included among the top collaborators of Patrick M. Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. Dolan. Patrick M. Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Comyns, Thomas M., et al.. (2023). Concussion And Subsequent Injuries In Amateur Community Rugby Union. Medicine & Science in Sports & Exercise. 55(9S). 83–83.
2.
Dolan, Patrick M., Thomas M. Comyns, Liam Glynn, Helen Purtill, & Ian C. Kenny. (2023). A Customized Warm-up Design And Controlled Feasibility Trial In Adult Amateur Rugby Union. Medicine & Science in Sports & Exercise. 55(9S). 724–725. 1 indexed citations
3.
Dolan, Patrick M., Ian C. Kenny, Liam Glynn, et al.. (2022). Risk factors for acute ankle sprains in field-based, team contact sports: a systematic review of prospective etiological studies. The Physician and Sportsmedicine. 51(6). 517–530. 6 indexed citations
4.
Kensler, Kevin H., Stephen L. Slocum, Dionysios V. Chartoumpekis, et al.. (2014). Genetic or Pharmacologic Activation of Nrf2 Signaling Fails to Protect Against Aflatoxin Genotoxicity in Hypersensitive GSTA3 Knockout Mice. Toxicological Sciences. 139(2). 293–300. 18 indexed citations
5.
Shin, Soona, Junko Wakabayashi, Melinda S. Yates, et al.. (2009). Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide. European Journal of Pharmacology. 620(1-3). 138–144. 237 indexed citations
6.
Yates, Melinda S., Quynh T. Tran, Patrick M. Dolan, et al.. (2009). Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis. 30(6). 1024–1031. 236 indexed citations
7.
Usera, Aimee, Patrick M. Dolan, Thomas W. Kensler, & Gary H. Posner. (2007). Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1α,25-dihydroxyvitamin D3: Chemical synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 15(16). 5509–5518. 19 indexed citations
8.
Osburn, William O., Baktiar Karim, Patrick M. Dolan, et al.. (2007). Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2‐deficient mice upon dextran sulfate treatment. International Journal of Cancer. 121(9). 1883–1891. 174 indexed citations
9.
Posner, Gary H., Kimberly S. Petersen, Patrick M. Dolan, et al.. (2007). Difluoromethyl analogs of the natural hormone 1α,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 213–221. 2 indexed citations
10.
Petersen, Kimberly S., Patrick M. Dolan, Thomas W. Kensler, Sara Peleg, & Gary H. Posner. (2007). Low-Calcemic, Highly Antiproliferative, 23-Oxa Ether Analogs of the Natural Hormone 1α,25-Dihydroxyvitamin D3:  Design, Synthesis, and Preliminary Biological Evaluation. Journal of Medicinal Chemistry. 50(23). 5824–5832. 8 indexed citations
11.
Peleg, Sara, et al.. (2005). A-ring hydroxymethyl 19-nor analogs of the natural hormone 1α,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation. Bioorganic & Medicinal Chemistry. 13(12). 3964–3976. 14 indexed citations
12.
Posner, Gary H., Hyung Jin Kim, Mehmet Kahraman, et al.. (2005). Highly antiproliferative, low-calcemic, side-chain ketone analogs of the hormone 1α,25-dihydroxyvitamin D3. Bioorganic & Medicinal Chemistry. 13(19). 5569–5580. 13 indexed citations
13.
Posner, Gary H., Kenneth Crawford, Hong Woon Yang, et al.. (2004). Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1α,25-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 5–12. 32 indexed citations
14.
Kahraman, Mehmet, Patrick M. Dolan, Thomas W. Kensler, et al.. (2004). Potent, Selective and Low-Calcemic Inhibitors of CYP24 Hydroxylase:  24-Sulfoximine Analogues of the Hormone 1α,25-Dihydroxyvitamin D3. Journal of Medicinal Chemistry. 47(27). 6854–6863. 89 indexed citations
15.
Kwak, Mi-Kyoung, Patricia A. Egner, Patrick M. Dolan, et al.. (2001). Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 480-481. 305–315. 199 indexed citations
16.
Kensler, Thomas W., Stephen J. Gange, Patricia A. Egner, et al.. (1997). Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.. PubMed. 6(8). 603–10. 39 indexed citations
17.
Egner, Patricia A., Stephen J. Gange, Patrick M. Dolan, et al.. (1995). Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis. 16(8). 1769–1773. 34 indexed citations
18.
Guyton, Kathryn Z., Patrick M. Dolan, & Thomas W. Kensler. (1994). Quinone methide mediates in vitro induction of ornithine decarboxylase by the tumor promoter butylated hydroxytoluene hydroperoxide. Carcinogenesis. 15(5). 817–821. 7 indexed citations
19.
Swauger, James E., Patrick M. Dolan, Jay L. Zweíer, Periannan Kuppusamy, & Thomas W. Kensler. (1991). Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. Chemical Research in Toxicology. 4(2). 223–228. 47 indexed citations
20.
Kensler, Thomas W., Patricia A. Egner, Patrick M. Dolan, John D. Groopman, & Bill D. Roebuck. (1987). Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.. PubMed. 47(16). 4271–7. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026